Literature DB >> 30585602

[Assessment of neurodevelopment in children of different gestational age with neonatal seizures].

A N Zavadenko1, M I Medvedev1, M G Degtyareva1.   

Abstract

AIM: To assess psychomotor development in infants with neonatal seizures (NS) born with different gestational age, by means of Bayley-III scales of infant and toddler development, in their corrected age of 1 year.
MATERIAL AND METHODS: The study included 52 infants, who had NS and were born with different gestational age: 28 weeks or less (n=26) - group I, 29-32 weeks (n=16) - group II, 33-36 weeks (n=3) - group III, 37-41 weeks (n=7) - group IV. The infants' neurodevelopment was evaluated in their corrected age of 1 year by means of N. Bayley scales of infant and toddler development, third edition: Cognitive, Language, Motor, Social-Emotional, and Adaptive Behavior. RESULTS AND
CONCLUSION: Only 17 (32,7%) of 52 examined infants did not demonstrate any developmental delay on each of five Bayley-III scales. Significant developmental delay (composite score <70) on at least one scale was revealed in 23 (44,2%) patients, including 12 (46,2%) in group I, 5 (31,3%) in group II, 6 (60%) of 10 in the combined group III-IV. In most cases, neurodevelopmental delays were attributed to only one domain and could be indicated as partial. The conclusion about global developmental retardation (the composite scores 55 or less on all five scales) was done in 3 patients, each of whom had a co-morbidity of cerebral palsy and epilepsy.

Entities:  

Keywords:  Bayley-III scales; cerebral palsy; epilepsy; neonatal seizures; neurodevelopment; preterm newborns

Mesh:

Year:  2018        PMID: 30585602     DOI: 10.17116/jnevro201811811135

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  1 in total

1.  A psychometric study of the Russian-language version of the "Bayley Scales of Infant and Toddler Development-third edition": An assessment of reliability and validity.

Authors:  Polina Pavlova; Dmitry Maksimov; Dmitry Chegodaev; Sergey Kiselev
Journal:  Front Psychol       Date:  2022-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.